MarketScan Research Databases

The gold standard in proprietary U.S. healthcare databases, the Thomson Reuters MarketScan® Research Databases provide researchers access to fully integrated, de-identified, individual-level healthcare claims data to understand health economics and treatment outcomes.

Several characteristics set MarketScan databases apart from other research databases. The core databases, Commercial, Medicare Supplemental, and Medicaid, are huge – nearly 150 million patients since 1995. Longitudinal integrity is strong. Complete payment information is captured, both what the benefit plan and patient paid. Specialty pharmacy and mail order are included. And, specialty databases link claims to unique data sets such as productivity management, health risk assessment, dental, lab, medical records, and hospital data at the de-identified patient level. A separate hospital database allows for in-hospital research. The MarketScan white paper provides additional detail on individual MarketScan databases.

MarketScan Research Online

We are helping researchers work faster and smarter by integrating and pre-summarizing data where possible, and offering online interfaces to improve access to the important insights that can be extracted from MarketScan data. Click here for more information on the MarketScan online tools.

Announcing Treatment Pathways 1.0

butterfly Marketscan Treatment thumbnailThomson Reuters MarketScan® Treatment Pathways is transforming how researchers work. Our newest online tool increases the speed by which researchers access and analyze data while revolutionizing their ability to collaborate with colleagues. Click here for more information.

Benefits

  • Fully integrated patient-level data (inpatient, outpatient, drug, lab, health and productivity management, health risk assessment, dental, and benefit design) from commercial, Medicare supplemental and Medicaid populations reflect real-world treatment patterns and costs
  • Fully integrated health and productivity data to assess indirect costs and burden of illness
  • Detailed hospital drug data to understand market drivers, monitor competitive challenges, and uncover new opportunities in the hospital marketplace
  • Rigorous validation methods to ensure that claims and enrollment data are complete, accurate, and reliable
  • Fully HIPAA compliant
  • Research based on MarketScan data published in more than 200 peer-reviewed articles in the past five years
  • Online tools for capturing quick facts and jump-starting studies